FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000581687> ?p ?o ?g. }

• W2000581687 endingPage "280" @default.
• W2000581687 startingPage "273" @default.
• W2000581687 abstract "A Phase I trial was performed to determine the maximum tolerated dose of concurrent preoperative radiation therapy (5040 cGy) and 2 cycles (bolus daily times 5) of 5-fluorouracil (5-FU) and low-dose leucovorin (LV) (20 mg/m2), followed by surgery and 10 cycles of postoperative 5-FU/LV in patients with primary or recurrent rectal cancer.Twenty-four patients were entered into the study. Preoperatively, the initial dose of 5-FU was 325 mg/m2. 5-FU was escalated 50 mg/m2, while the dose of LV and radiation therapy remained constant. Chemotherapy and radiation began concurrently on day 1. The postoperative chemotherapy was not dose escalated; 5-FU, 425 mg/m2, and LV, 20 mg/m2. The median follow-up was 10 months (range, 4-19 months).The resectability rate with negative margins in the 23 patients who underwent surgery was 100%. One patient refused surgery. The pathologic complete response rate was 13% (3 of 23). An additional four patients had negative nodes and a microscopic foci of tumor in the bowel wall. Therefore, the total clinical complete response rate was 30% (7 of 23). The maximum tolerated dose of 5-FU for the preoperative combined modality segment was 375 mg/m2; therefore, the recommended Phase II dose level is 325 mg/m2. The incidence of Grade 3+ toxicity for the 22 patients treated at the recommended 5-FU dose level (325 mg/m2) during the preoperative combined modality segment was as follows: diarrhea, 14%; erythema, 5%; hematologic, 10%; and total, 18%. The median nadir counts were leukocyte count, 3.7 (range, 1.5-5.9); hemoglobin count, 12.2 (range, 10.2-14.3); and platelet count (times 1000), 165 (range, 92-237).With this regimen, the recommended doses of chemotherapy in the combined modality segment are slightly higher than those recommended in arm 2 of the Intergroup postoperative adjuvant rectal trial 0114. This regimen will serve both as the preoperative arm of the Intergroup randomized trial of preoperative versus postoperative combined modality therapy for resectable rectal cancer (INT R9401) as well as the basis for the combined modality segment of NSABP RO-3." @default.
• W2000581687 created "2016-06-24" @default.
• W2000581687 creator A5004108255 @default.
• W2000581687 creator A5005278958 @default.
• W2000581687 creator A5025191979 @default.
• W2000581687 creator A5033566588 @default.
• W2000581687 creator A5035865205 @default.
• W2000581687 creator A5037120205 @default.
• W2000581687 creator A5050959367 @default.
• W2000581687 creator A5069644669 @default.
• W2000581687 creator A5069929201 @default.
• W2000581687 creator A5087201995 @default.
• W2000581687 date "1994-01-15" @default.
• W2000581687 modified "2023-10-10" @default.
• W2000581687 title "Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancer" @default.
• W2000581687 cites W1844072307 @default.
• W2000581687 cites W1948899169 @default.
• W2000581687 cites W1964576482 @default.
• W2000581687 cites W1975194596 @default.
• W2000581687 cites W1976432234 @default.
• W2000581687 cites W1994949219 @default.
• W2000581687 cites W1997355333 @default.
• W2000581687 cites W2003349354 @default.
• W2000581687 cites W2027805048 @default.
• W2000581687 cites W2043691565 @default.
• W2000581687 cites W2053325046 @default.
• W2000581687 cites W2061193866 @default.
• W2000581687 cites W2080980694 @default.
• W2000581687 cites W2092910824 @default.
• W2000581687 cites W2155789163 @default.
• W2000581687 cites W2159461712 @default.
• W2000581687 cites W2270670838 @default.
• W2000581687 cites W4246964235 @default.
• W2000581687 doi "https://doi.org/10.1002/1097-0142(19940115)73:2<273::aid-cncr2820730207>3.0.co;2-4" @default.
• W2000581687 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8293388" @default.
• W2000581687 hasPublicationYear "1994" @default.
• W2000581687 type Work @default.
• W2000581687 sameAs 2000581687 @default.
• W2000581687 citedByCount "129" @default.
• W2000581687 countsByYear W20005816872012 @default.
• W2000581687 countsByYear W20005816872018 @default.
• W2000581687 countsByYear W20005816872021 @default.
• W2000581687 crossrefType "journal-article" @default.
• W2000581687 hasAuthorship W2000581687A5004108255 @default.
• W2000581687 hasAuthorship W2000581687A5005278958 @default.
• W2000581687 hasAuthorship W2000581687A5025191979 @default.
• W2000581687 hasAuthorship W2000581687A5033566588 @default.
• W2000581687 hasAuthorship W2000581687A5035865205 @default.
• W2000581687 hasAuthorship W2000581687A5037120205 @default.
• W2000581687 hasAuthorship W2000581687A5050959367 @default.
• W2000581687 hasAuthorship W2000581687A5069644669 @default.
• W2000581687 hasAuthorship W2000581687A5069929201 @default.
• W2000581687 hasAuthorship W2000581687A5087201995 @default.
• W2000581687 hasConcept C121608353 @default.
• W2000581687 hasConcept C126322002 @default.
• W2000581687 hasConcept C141071460 @default.
• W2000581687 hasConcept C2776694085 @default.
• W2000581687 hasConcept C2779121184 @default.
• W2000581687 hasConcept C2780456651 @default.
• W2000581687 hasConcept C2989005 @default.
• W2000581687 hasConcept C43376680 @default.
• W2000581687 hasConcept C509974204 @default.
• W2000581687 hasConcept C526805850 @default.
• W2000581687 hasConcept C71924100 @default.
• W2000581687 hasConcept C90924648 @default.
• W2000581687 hasConceptScore W2000581687C121608353 @default.
• W2000581687 hasConceptScore W2000581687C126322002 @default.
• W2000581687 hasConceptScore W2000581687C141071460 @default.
• W2000581687 hasConceptScore W2000581687C2776694085 @default.
• W2000581687 hasConceptScore W2000581687C2779121184 @default.
• W2000581687 hasConceptScore W2000581687C2780456651 @default.
• W2000581687 hasConceptScore W2000581687C2989005 @default.
• W2000581687 hasConceptScore W2000581687C43376680 @default.
• W2000581687 hasConceptScore W2000581687C509974204 @default.
• W2000581687 hasConceptScore W2000581687C526805850 @default.
• W2000581687 hasConceptScore W2000581687C71924100 @default.
• W2000581687 hasConceptScore W2000581687C90924648 @default.
• W2000581687 hasIssue "2" @default.
• W2000581687 hasLocation W20005816871 @default.
• W2000581687 hasLocation W20005816872 @default.
• W2000581687 hasOpenAccess W2000581687 @default.
• W2000581687 hasPrimaryLocation W20005816871 @default.
• W2000581687 hasRelatedWork W177976942 @default.
• W2000581687 hasRelatedWork W1990073046 @default.
• W2000581687 hasRelatedWork W2009729947 @default.
• W2000581687 hasRelatedWork W2017564324 @default.
• W2000581687 hasRelatedWork W2021802122 @default.
• W2000581687 hasRelatedWork W2363374489 @default.
• W2000581687 hasRelatedWork W2379596026 @default.
• W2000581687 hasRelatedWork W2424894649 @default.
• W2000581687 hasRelatedWork W632620057 @default.
• W2000581687 hasRelatedWork W2521740187 @default.
• W2000581687 hasVolume "73" @default.
• W2000581687 isParatext "false" @default.
• W2000581687 isRetracted "false" @default.
• W2000581687 magId "2000581687" @default.
• W2000581687 workType "article" @default.